MDT vs RMD
MDT: Medtronic is a global healthcare technology leader dedicated to alleviating pain, restoring health, and extending life through innovative medical devices and digital solutions. RMD: ResMed is a leading provider of AI-powered, cloud-connected medical devices and software that revolutionize the management of sleep apnea and chronic respiratory conditions at home.
Side-by-side fundamentals
| Metric | MDT | RMD | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $87.75 | $226.73 | |
| Market cap | $112.2B | $32.7B | |
| P/E as of 2026-10-08 | 23.54 | 21.73 | RMD lower |
| PEG as of 2026-10-08, 3-year EPS CAGR to FY2026 | 2.41 | 1.11 | RMD lower |
| Net margin FY2026, SEC XBRL | +13.2% | +26.9% | RMD higher |
| Gross margin FY2026, SEC XBRL | n/a | +61.1% | |
| Operating margin FY2026, SEC XBRL | +17.8% | +33.4% | RMD higher |
| ROE FY2026, SEC XBRL | +9.7% | +23.1% | RMD higher |
| ROA FY2026, SEC XBRL | +5.2% | +17.0% | RMD higher |
| Debt / equity as of 2026-09-03 | 0.57 | 0.10 | RMD lower |
| Revenue growth (YoY) as of 2026-09-03 | +8.4% | +9.8% | RMD higher |
| Revenue CAGR (3y) SEC XBRL | +5.2% | +10.2% | RMD higher |
| Dividend yield as of 2026-09-03 | +3.1% | +1.2% | MDT higher |
| Dividend streak (yrs) SEC XBRL | 14 | 14 | Tie |
| Beta as of 2026-09-03 | 0.36 | 0.58 | |
| 1-year return as of 2026-10-08 close | -10.3% | -19.7% | MDT higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.